Maculaser develops novel medical technology for treatment of common retinal diseases, including dry Age-related Macular Degeneration. The core of our innovation is the precise temperature control of the macula during non-damaging laser treatments; a potential game changer in the practise of how major retinal diseases, with over USD 400B direct health care costs, are being treated in the future. Our innovations allow clinicians to perform previously infeasible laser therapy and potentially help millions of people to retain their vision.
| Website | http://www.maculaser.com |
| Employees | 5 (5 on RocketReach) |
| Founded | 2020 |
| Technologies |
JavaScript
,
HTML
,
PHP
+11 more
(view full list)
|
| Industry | Medical Equipment Manufacturing |
| Keywords | Retinal Diseases, Age-Related Macular Degeneration, Macular Degeneration Treatment, Ophthalmology, Medical Technology, Eye Disease Treatment, Vision Care Technology |
| Competitors | Abbott, Genentech, Alcon, ZEISS Group, Bausch + Lomb, Lumenis, HOYA Surgical Optics, Santen, Aerie Pharmaceuticals, Caron Products +25 more (view full list) |
Looking for a particular Maculaser Ltd employee's phone or email?
Maculaser Ltd Questions
Jani Tirronen is the CEO and Co-Founder of Maculaser Ltd.
5 people are employed at Maculaser Ltd.
Maculaser Ltd is based in Helsinki, Uusimaa.
Top Maculaser Ltd Employees
-
Jani Tirronen
CEO and Co-Founder at Maculaser Ltd
Helsinki, FI21 -
1
-
1
